Behavioral and biochemical investigations of bupropion metabolites
- PMID: 12909199
- DOI: 10.1016/s0014-2999(03)02010-7
Behavioral and biochemical investigations of bupropion metabolites
Abstract
The stimulus effects of bupropion metabolites were examined in a drug discrimination procedure using (-)nicotine- and (+)amphetamine-trained rats. (+)- and (-)threohydrobupropion partially substituted in each group. R,R-hydroxybupropion produced vehicle-appropriate responding in (-)nicotine animals but, when given in combination with the training dose of (-)nicotine, resulted in an attenuated effect. S,S-Hydroxybupropion partially (66%) substituted for (-)nicotine. In (+)amphetamine-trained animals, S,S-hydroxybupropion (ED50=4.4 mg/kg) generalized completely and was similar in potency to bupropion (ED50=5.4 mg/kg). Bupropion and its metabolites lacked affinity for nicotinic acetylcholinergic receptors, but all antagonized (-)nicotine-induced 86Rb+ efflux in cells expressing alpha3beta4 nicotinic cholinergic receptors. S,S-Hydroxybupropion possessed affinity at the dopamine transporter comparable to bupropion, and was also found to bind at the norepinephrine transporter. Although it is unlikely that any metabolite isomer is chiefly responsible for the stimulus actions of bupropion, some probably play a role in the complex actions of this agent.
Similar articles
-
Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeys.Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):196-203. doi: 10.1097/FBP.0000000000000224. Behav Pharmacol. 2016. PMID: 26886209 Free PMC article.
-
Nicotine and bupropion share a similar discriminative stimulus effect.Eur J Pharmacol. 2002 May 17;443(1-3):113-8. doi: 10.1016/s0014-2999(02)01554-6. Eur J Pharmacol. 2002. PMID: 12044800
-
An investigation of bupropion substitution for the interoceptive stimulus effects of nicotine.J Psychopharmacol. 2010 Jun;24(6):817-28. doi: 10.1177/0269881109102518. Epub 2009 Mar 20. J Psychopharmacol. 2010. PMID: 19304864 Free PMC article.
-
Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.CNS Drug Rev. 2006 Fall-Winter;12(3-4):178-207. doi: 10.1111/j.1527-3458.2006.00178.x. CNS Drug Rev. 2006. PMID: 17227286 Free PMC article. Review.
-
Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects.Drug Metab Rev. 2019 Aug;51(3):293-313. doi: 10.1080/03602532.2019.1620763. Epub 2019 Jun 14. Drug Metab Rev. 2019. PMID: 31124380 Review.
Cited by
-
Identification of non-reported bupropion metabolites in human plasma.Biopharm Drug Dispos. 2016 Dec;37(9):550-560. doi: 10.1002/bdd.2046. Biopharm Drug Dispos. 2016. PMID: 27723114 Free PMC article.
-
Stereoselective Glucuronidation of Bupropion Metabolites In Vitro and In Vivo.Drug Metab Dispos. 2016 Apr;44(4):544-53. doi: 10.1124/dmd.115.068908. Epub 2016 Jan 22. Drug Metab Dispos. 2016. PMID: 26802129 Free PMC article. Clinical Trial.
-
Central nervous system biogenic amine targets for control of appetite and energy expenditure.Endocrine. 2006 Feb;29(1):49-60. doi: 10.1385/endo:29:1:49. Endocrine. 2006. PMID: 16622292 Review.
-
Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.J Med Chem. 2010 Jun 24;53(12):4731-48. doi: 10.1021/jm1003232. J Med Chem. 2010. PMID: 20509659 Free PMC article.
-
Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation.Eur J Clin Pharmacol. 2009 Apr;65(4):403-9. doi: 10.1007/s00228-008-0594-3. Epub 2008 Dec 9. Eur J Clin Pharmacol. 2009. PMID: 19066872
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
